210Pb: A predictive biomarker of retrospective cigarette smoke exposure

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 2, 2010, Pages 338-350

  Schayer, Stephen R ^a   Qu, Qingshan ^a   Wang, Yanling ^b   Cohen, Beverly S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CIGARETTE SMOKE; COTININE; LEAD 210; POLONIUM; CREATININE; LEAD;

ADULT; AGED; ARTICLE; CHINA; CONTROLLED STUDY; EXPOSURE; FEMALE; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOACTIVITY; SMOKING CESSATION; SMOKING HABIT; STEADY STATE; URINALYSIS; URINE LEVEL; MIDDLE AGED; SMOKING; STATISTICAL MODEL; URINE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COTININE; CREATININE; FEMALE; HALF-LIFE; HUMANS; LEAD RADIOISOTOPES; LOGISTIC MODELS; MALE; MIDDLE AGED; SMOKING; YOUNG ADULT;

EID: 76149130993     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-1008     Document Type: Article

References (41)

1. Mackay J, Eriksen M. The tobacco atlas. Brighton (UK): WHO; 2002.
2. Jarvis MJ, Russell MAH, Benowitz NL, Feyerabend C. Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health 1988;78:696-8.
3. Benowitz NL. Nicotine addiction. Prim Care 1999;26:611-31.
4. Hatsukami DK, Hecht SS, Hennrikus DJ, Joseph AM, Pentel PR. Biomarkers of tobacco exposure and harm: application to clinical and epidemiological studies. Nicotine Tob Res 2003;5:387-96.
5. Hecht SS, Carmella SG, Chen M, et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res 1999;59:590-6.
6. Carmella SG, Akerkar SA, Richie JP, Hecht SS. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev 1995;4:635-42.
7. Joseph AM, Hecht SS, Murphy SE, et al. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev 2005;14:2963-8.
8. Stepanov I, Hecht SS, Lindgren B, Jacob P, Wilson M, Benowitz N. Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine. Cancer Epidemiol Biomarkers Prev 2007;16:1382-6.
9. Caraballo RS, Giovino GA, Pechacek TF. Self-reported cigarette smoking vs. serum cotinine among U.S. adolescents. Nicotine Tob Res 2004;6:19-25.
10. Caraballo RS, Giovino GA, Pechacek TF, Mowery PD. Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2001;153:807-14.
11. Vartiainen E, Seppala T, Lillsunde P, Puska P. Validation of self reported smoking by serum cotinine measurement in a communitybased study. J Epidemiol Commun H 2002;56:167-70.
12. Fendrich M, Mackesy-Amiti ME, Johnson TP, Hubbell A, Wislar JS. Tobacco-reporting validity in an epidemiological drug-use survey. Addict Behav 2005;30:175-81.
13. Perez-Stable EJ, Marin BV, Marin G, Brody DJ, Benowitz NL. Apparent underreporting of cigarette consumption among Mexican American smokers. Am J Public Health 1990;80:1057-61.
14. Boyd NR, Windsor RA, Perkins LL, Lowe JB. Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women. Matern Child Healt J 1998;2:77-83.
15. Lewis SJ, Cherry NM, Niven RM, Barber PV, Wilde K, Povey AC. Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinic. Biomarkers 2003;8:218-28.
16. Tso TC, Harley N, Alexander LT. Source of lead-210 and polonium-210 in tobacco. Science 1966;153:880-2.
17. Martell EA. Radioactivity of tobacco trichomes and insoluble cigarette smoke particles. Nature 1974;249:215-7.
18. 210Pb in Chinese cigarettes. Health Phys 2009;96:543-9.
19. Harley NH, Cohen BS. Polonium-210 in tobacco. In: Moghissi AA, Paras P, Carter MW, Barker RF, editors. Radioactivity in consumer products. Washington, DC: U.S. Nuclear Regulatory Commission; 1978, p. 199-216.
20. Cohen BS, Eisenbud M, Harley NH. Alpha radioactivity in cigarette smoke. Radiat Res 1980;83:190-6.
21. International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans: inorganic and organic lead compounds. Lyons (France): WHO International Agency for Research on Cancer; 2006.
22. Leggett RW, Eckerman KF. A systemic biokinetic model for polonium. Sci Total Environ 2001;275:109-25.
23. Hill CR. Polonium-210 in man. Nature 1965;208:423-8.
24. Holtzman RB, Ilcewicz FH. Lead-210 and polonium-210 in tissues of cigarette smokers. Science 1966;153:1259-60.
25. Rajewsky B, Stahlhofen W. Polonium-210 activity in the lungs of cigarette smokers. Nature 1966;209:1312-3.
26. 210Po in human soft tissues. Health Phys 1967;13:625-32.
27. Cohen BS, Eisenbud M, Wrenn ME, Harley NH. Distribution of polonium-210 in the human lung. Radiat Res 1979;79:162-8.
28. Little JB, McGandy RB. Measurement of polonium-210 in human blood. Nature 1966;211:842-3.
29. Shabana EI, Abd Elaziz MA, Al-Arifi MN, Al-Dhawailie AA, Al-Bokari MM. Evaluation of the contribution of smoking to total blood polonium-210 i n a Saudi population. Applied Radiat Isotopes 2000;52:23-6.
30. Santos PL, Gouvea RC, Dutra IR. Concentrations of Pb-210 and Po-210 in hair and urine of workers of the uranium mines at Pocos de Caldas (Brazil). Sci Total Environ 1994;148:61.
31. Azeredo AMGF, Lipsztein JL. Polonium-210 excretion in urine: a comparison of an occupational exposed group and a control. Radiat Prot Dosim 1991;36:51.
32. HASL-300 Manual. Polonium in water and urine Po-01-RC [Internet]. New York: U.S. Department of Energy Environmental Measurements Laboratory; 1997. Available from: http://www.eml.st.dhs.gov/publications/procman.cfm.
33. International Commission on Radiological Protection (ICRP). Publication 66: human respiratory tract model for radiological protection. Ann ICRP 1994;24:1-482.
34. International Commission on Radiological Protection (ICRP). Publication 30: annual limits on intakes for workers, part 1. Ann ICRP 1979;2:1-116.
35. International Commission on Radiological Protection (ICRP). Publication 67: age-dependent doses to members of the public from intake of radionuclides, part 2. Ann ICRP 1993;23:1-167.
36. Macey RI, Oster GF. Berkeley Madonna software version 8.3.14 [Internet]. 2006. Available from: http://www.berkeleymadonna.com.
37. 210Po as tracers of cigarette smoke exposure [dissertation]. Ann Arbor (MI): ProQuest UMI Dissertation Publishing, In press, 2010.
38. Jatlow P, McKee S, O'Malley S. Correction of urine cotinine concentrations for creatinine excretion: is it useful? Clin Chem 2003;49:1932-4.
39. Thomas PA, Fisenne I, Chorney D, Baweja AS, Tracy BL. Human absorption and retention of polonium-210 from caribou meat. Radiat Prot Dosim 2001;97:241-50.
40. Leggett RW. An age-specific kinetic model of lead metabolism in humans. Environ Health Persp 1993;101:598-616.
41. 210Po determination in urines of people living in central Italy. J Environ Radioactiv 2009; 100:84-8.